<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
      <meta name="robots" content="noindex, nofollow">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Oxford–AstraZeneca (Vaxzevria) — Timeline, Informed-Consent Context, Individual Record, and Evidence (James Saint)</title>
  <meta name="description" content="Source-linked AstraZeneca timeline, informed-consent context for a 1977-born adult, James Saint’s vaccination entries, and supporting GP-record evidence with legal framing and file index." />

  <!-- Open Graph -->
  <meta property="og:title" content="AstraZeneca — Timeline, Consent, Record, and Evidence" />
  <meta property="og:description" content="Source-linked history, consent context, personal record, and scanned GP evidence for legal review." />
  <meta property="og:type" content="article" />
  <meta property="og:image" content="https://jamessaint.github.io/images/seed-of-life-gold-default.png" />

  <!-- Twitter Card -->
  <meta name="twitter:card" content="summary_large_image" />
  <meta name="twitter:title" content="AstraZeneca — Timeline, Consent, Record, and Evidence" />
  <meta name="twitter:description" content="Source-linked history, consent context, personal record, and scanned GP evidence for legal review." />
  <meta name="twitter:image" content="https://jamessaint.github.io/images/seed-of-life-gold-default.png" />

  <!-- Bootstrap + Montserrat -->
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet" />
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
<link href="global_styles.css" rel="stylesheet" />
</head>
<body>
<main class="content container">

<header>
  <h1>Oxford–AstraZeneca (Vaxzevria) COVID-19 Vaccine</h1>
  <p class="meta">Timeline, informed-consent context for a person born September 1977, individual vaccination record, and scanned GP-record evidence for legal review.</p>
</header>

<!-- DOWNLOADS PANEL -->
<section class="section card-like downloads">
  <h2>Downloads</h2>
  <p>Presentation-ready, lightly cleaned PNGs (with neutral footer watermark) and a ZIP bundle with README:</p>
  <p>
    <a class="btn btn-success btn-sm" href="images/AstraZeneca_Evidence_Images_JamesSaint.zip">Download ZIP — AstraZeneca_Evidence_Images_JamesSaint.zip</a>
    <a class="btn btn-outline-primary btn-sm" href="images/2021-03-31_Home_Visit_SMS.png">2021-03-31_Home_Visit_SMS.png</a>
    <a class="btn btn-outline-primary btn-sm" href="images/2021-04-01_First_Dose_Record.png">2021-04-01_First_Dose_Record.png</a>
    <a class="btn btn-outline-primary btn-sm" href="images/2021-06-22_Second_Dose_Record.png">2021-06-22_Second_Dose_Record.png</a>
  </p>
  <div class="note">
    Provenance watermark on each image: <em>“Source: GP record provided to patient – April 2025”</em>. A <span class="images/README.txt">README.txt</span> inside the ZIP lists SHA-256 hashes for evidential integrity.
  </div>
</section>

<section class="section card-like">
  <h2>At a Glance</h2>
  <ul>
    <li><strong>Development</strong> began Jan–Apr 2020 by Oxford Jenner Institute; partnership with AstraZeneca announced
      <a href="https://www.ox.ac.uk/news/2020-04-30-oxford-university-announces-landmark-partnership-astrazeneca-development-and" target="_blank" rel="noopener">30 Apr 2020</a>.
    </li>
    <li><strong>UK authorisation</strong> granted
      <a href="https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator" target="_blank" rel="noopener">30 Dec 2020</a>.
    </li>
    <li><strong>EMA confirmed very rare TTS risk</strong> on
      <a href="https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" target="_blank" rel="noopener">7 Apr 2021</a>.
    </li>
    <li><strong>JCVI advised alternatives for 30–39</strong> when available on
      <a href="https://www.gov.uk/government/news/jcvi-advises-on-covid-19-vaccine-for-people-aged-under-40" target="_blank" rel="noopener">7 May 2021</a>.
    </li>
    <li><strong>EU marketing authorisation withdrawn</strong>
      <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria" target="_blank" rel="noopener">27 Mar 2024</a> (effective 7 May 2024).
    </li>
    <li><strong>Global discontinuation</strong> reported May 2024
      <a href="https://apnews.com/article/a3c108dd0ca305cf1b6da764e9a37abc" target="_blank" rel="noopener">AP</a>,
      <a href="https://www.theguardian.com/business/article/2024/may/08/astrazeneca-withdraws-covid-19-vaccine-worldwide-citing-surplus-of-newer-vaccines" target="_blank" rel="noopener">Guardian</a>.
    </li>
  </ul>
</section>

<section class="section card-like">
  <h2>Dated Timeline with Sources</h2>
  <table>
    <thead><tr><th>Date</th><th>Event</th><th>Source</th></tr></thead>
    <tbody>
      <tr><td>Feb–Apr 2020</td><td>Design and early trials</td><td><a href="https://www.ox.ac.uk/news/2020-04-30-oxford-university-announces-landmark-partnership-astrazeneca-development-and" target="_blank">Oxford</a></td></tr>
      <tr><td>30 Dec 2020</td><td>MHRA authorises vaccine in UK</td><td><a href="https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator" target="_blank">DHSC</a></td></tr>
      <tr><td>7 Apr 2021</td><td>EMA identifies possible link to rare clotting with low platelets</td><td><a href="https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" target="_blank">EMA</a></td></tr>
      <tr><td>7 May 2021</td><td>JCVI recommends alternatives for 30–39 when available</td><td><a href="https://www.gov.uk/government/news/jcvi-advises-on-covid-19-vaccine-for-people-aged-under-40" target="_blank">JCVI</a></td></tr>
      <tr><td>27 Mar 2024</td><td>EU withdrawal of marketing authorisation</td><td><a href="https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria" target="_blank">EMA EPAR</a></td></tr>
      <tr><td>May 2024</td><td>Global discontinuation reported</td><td><a href="https://apnews.com/article/a3c108dd0ca305cf1b6da764e9a37abc" target="_blank">AP</a></td></tr>
    </tbody>
  </table>
</section>

<section class="section card-like">
  <h2>Informed-Consent Context -1977 Birth Year</h2>
  <ul>
    <li><strong>7 Apr 2021:</strong> EMA lists thrombosis with thrombocytopenia as a very rare side effect and updates product information
      <a href="https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" target="_blank" rel="noopener">EMA PRAC</a>.
    </li>
    <li><strong>7 May 2021:</strong> JCVI advises alternatives for adults 30–39 without risk factors where available
      <a href="https://www.gov.uk/government/news/jcvi-advises-on-covid-19-vaccine-for-people-aged-under-40" target="_blank" rel="noopener">JCVI Statement</a>.
    </li>
    <li><strong>Recipient information:</strong> patient leaflets and UK recipient pages maintained on Gov.uk
      <a href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/patient-information-leaflet-for-covid-19-vaccine-astrazeneca" target="_blank" rel="noopener">PIL</a>.
    </li>
  </ul>
  <div class="note">
    For a 43–44 year-old, formal TTS warnings were issued from 7 Apr 2021. After that date, disclosure should have been part of updated materials. JCVI did not restrict AstraZeneca for those over 40.
  </div>
</section>

<section id="record" class="section card-like">
  <h2>Individual Vaccination Record (from GP Notes)</h2>
  <table>
    <thead>
      <tr><th>Date (recorded)</th><th>Dose</th><th>Product</th><th>Batch</th><th>Route / Site</th><th>Recorded Location</th><th>Entered by</th></tr>
    </thead>
    <tbody>
      <tr>
        <td>01 Apr 2021 15:33</td>
        <td>First dose</td>
        <td>COVID-19 Vaccine Vaxzevria (ChAdOx1-S) 0.5 ml</td>
        <td>Batch No: <strong>PW40008</strong></td>
        <td>Intramuscular, Left deltoid</td>
        <td>Not stated in extract</td>
        <td>ANSCOMBE, Sonya (Mrs)</td>
      </tr>
      <tr>
        <td>22 Jun 2021 16:49</td>
        <td>Second dose</td>
        <td>COVID-19 Vaccine Vaxzevria (ChAdOx1-S) 0.5 ml</td>
        <td>Batch No: <strong>PV46690</strong></td>
        <td>Intramuscular, Left deltoid</td>
        <td>N9J0U — Emsworth Baptist Church</td>
        <td>ANSCOMBE, Sonya (Mrs)</td>
      </tr>
    </tbody>
  </table>

  <div class="note">
    <strong>Patient statement:</strong> both doses were administered at home by two nurses from Emsworth Medical Practice due to severe PTSD and agoraphobia documented in contemporaneous records. The second-dose entry lists the Baptist Church site code; this conflicts with the patient’s recollection of home administration.
  </div>
</section>

<section id="evidence" class="section card-like">
  <h2>Scanned GP-Record Evidence</h2>

  <p>Below are the legally framed exhibits. Each figure caption identifies the file and a brief excerpt to aid rapid review. Original GP-supplied files should be preserved unchanged; the PNGs here are presentation copies.</p>

  <figure class="mb-3">
    <img src="images/GP_SMS_Home_Visit_2021-03-31.png" class="img-fluid" alt="31-Mar-2021 SMS note offering home visit for 1 Apr vaccine" />
    <figcaption>
      <strong>Figure 1.</strong> <span class="images/GP_SMS_Home_Visit_2021-03-31.png">2021-03-31_Home_Visit_SMS.png</span> — 31-Mar-2021, 14:46. Practice SMS arranging a <em>home visit</em> for 1 Apr.
      <blockquote class="small">Excerpt: “We will call at your house for your vaccine tomorrow (1 April).”</blockquote>
    </figcaption>
  </figure>

  <figure class="mb-3 mt-3">
    <img src="images/GP_First_Dose_Entry_2021-04-01.png" class="img-fluid" alt="01-Apr-2021 first dose record with batch PW40008, IM left deltoid" />
    <figcaption>
      <strong>Figure 2.</strong> <span class="images/GP_First_Dose_Entry_2021-04-01.png">2021-04-01_First_Dose_Record.png</span> — 01-Apr-2021 first-dose entry.
      <blockquote class="small">Excerpt: “COVID-19 Vaccine Vaxzevria (ChAdOx1-S) 0.5 ml — Batch PW40008 — IM — Left deltoid.”</blockquote>
    </figcaption>
  </figure>

  <figure class="mb-3 mt-3">
    <img src="images/GP_Second_Dose_Entry_2021-06-22.png" class="img-fluid" alt="22-Jun-2021 second dose record with batch PV46690 and location N9J0U Emsworth Baptist Church" />
    <figcaption>
      <strong>Figure 3.</strong> <span class="filename">2021-06-22_Second_Dose_Record.png</span> — 22-Jun-2021 second-dose entry.
      <blockquote class="small">Excerpt: “Batch PV46690 — Site: N9J0U (Emsworth Baptist Church) — IM — Left deltoid.”</blockquote>
    </figcaption>
  </figure>

  <h2 class="mt-4">Evidence File Index</h2>
  <table>
    <thead>
      <tr><th>Exhibit</th><th>Filename</th><th>Date</th><th>Content summary</th><th>Key excerpt</th></tr>
    </thead>
    <tbody>
      <tr>
        <td>Fig. 1</td>
        <td class="filename">2021-03-31_Home_Visit_SMS.png</td>
        <td>31-Mar-2021</td>
        <td>Practice SMS arranging <em>home visit</em> for 1 Apr vaccination</td>
        <td>“We will call at your house for your vaccine tomorrow (1 April).”</td>
      </tr>
      <tr>
        <td>Fig. 2</td>
        <td class="filenames">2021-04-01_First_Dose_Record.png</td>
        <td>01-Apr-2021</td>
        <td>First dose entry; product, batch and route recorded</td>
        <td>“Vaxzevria (ChAdOx1-S) 0.5 ml — Batch PW40008 — IM — Left deltoid.”</td>
      </tr>
      <tr>
        <td>Fig. 3</td>
        <td class="filename">2021-06-22_Second_Dose_Record.png</td>
        <td>22-Jun-2021</td>
        <td>Second dose entry with mass-site code recorded</td>
        <td>“Batch PV46690 — Site: N9J0U (Emsworth Baptist Church).”</td>
      </tr>
    </tbody>
  </table>

  <!-- New: Patient Statement & Discrepancy Analysis -->
  <h2 class="mt-4">Patient Statement & Discrepancy Analysis</h2>
  <div class="callout">
    <p><strong>Patient Statement (James Saint):</strong> “Both COVID-19 vaccine doses were administered at my home by two nurses from Emsworth Medical Practice. I was house-bound at the time with severe PTSD and agoraphobia. I did not feel I was given informed consent or appropriate care for a house-bound patient. The visit felt rushed and impersonal.”</p>
    <p><strong>Documented Records:</strong></p>
    <ul>
      <li><em>Fig. 1 (31-Mar-2021 SMS)</em> indicates a planned <strong>home visit</strong> for vaccination on 1 April.</li>
      <li><em>Fig. 2 (01-Apr-2021 entry)</em> records first-dose administration details (product, batch, site=left deltoid) but <strong>no location</strong> is specified in the extract.</li>
      <li><em>Fig. 3 (22-Jun-2021 entry)</em> records second dose with site code <strong>N9J0U — Emsworth Baptist Church</strong>, which <strong>conflicts</strong> with the patient’s account of a home administration.</li>
    </ul>
    <p><strong>Analysis:</strong> The record set contains an internal inconsistency regarding administration location across the two doses. The contemporaneous SMS supports home attendance on 1 April; the second-dose entry lists a mass-site code. This discrepancy should be addressed via audit logs (e.g., NIVS/Pinnacle event data, site-code mapping) and, if appropriate, corrected or annotated with a patient statement.</p>
    <p class="mb-0"><strong>Note:</strong> The statements above reflect the patient’s account. Determinations about consent adequacy and documentation accuracy should be made by reviewing clinicians and/or the practice after examining the complete record and audit trail.</p>
  </div>

  <div class="note mt-3">
    <strong>Provenance and chain-of-custody checklist:</strong>
    <ul>
      <li>Preserve original PDFs/images as received from the GP surgery, unedited.</li>
      <li>Record file hashes (e.g., SHA-256). The <span class="images/README.txt">README.txt</span> inside the ZIP includes current hashes for these PNGs.</li>
      <li>Request vaccination event audit logs (NIVS/Pinnacle), including site code, vaccinator IDs, and administering address.</li>
      <li>If correction is refused, add this statement as a supplementary note under UK GDPR Article 16 (right to rectification).</li>
    </ul>
  </div>
</section>

<section class="section card-like">
  <h2>Record Accuracy & Rectification</h2>
  <ul>
    <li>Ask for the NIVS/Pinnacle event logs for both doses, including site code used and vaccinator IDs.</li>
    <li>Request written confirmation of the administering address for each dose, or an explanation for site-code attribution where a home visit was performed.</li>
    <li>Provide this document with your statement as a supplementary note for attachment to the entries if the practice declines amendment.</li>
  </ul>
</section>

<section class="section card-like">
  <h2>Statement of Truth</h2>
  <p>I, James Saint, confirm that the statements in this document are true to the best of my knowledge and belief. I understand that it may be placed before clinicians and, if required, a court or tribunal.</p>
  <p>Signed: ____________________________ &nbsp; Date: ____ / ____ / ______</p>
</section>

</main>
</body>
</html>
